Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WISTAMA Finanz- und Beteiligungs AG is a Swiss-based family office and holding company for the Stadler family, headquartered in Altstätten. The firm is the majority owner of icotec ag, a prominent medical technology company specializing in radiolucent carbon-fiber-reinforced spinal implants (BlackArmor) designed to improve radiation therapy for cancer patients. WISTAMA also maintains significant ownership in the SFS Group, a global industrial leader with a substantial medical device division, and POLYGENA AG. As a long-term investment vehicle, the company focuses on supporting the growth and succession of innovative industrial and healthcare enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WISTAMA Finanz- und Beteiligungs.